Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Paricalcitol may cause cancer cells to look more like normal cells, and to grow
and spread more slowly. Drugs used in chemotherapy, such as gemcitabine, work in different
ways to stop the growth of cancer cells, either by killing the cells or by stopping them from
dividing. Giving paricalcitol together with gemcitabine may be an effective treatment for
cancer.
PURPOSE: This phase I trial is studying the side effects and best dose of paricalcitol when
given together with gemcitabine in treating patients with advanced cancer.